HeartSciences HSCS
NASDAQ HSCS
$4.12 +0.04 (+0.98%)
At close: Sep 9, 2026 · 4:00 PM EDT

HeartSciences Inc. (HSCS) EBT Margin (2021 - 2025)

HeartSciences' (HSCS) quarterly EBT Margin came in at 97269.0% in Q4 2025, up 10.19% quarter-over-quarter from 108305.63% in Q3 2025.

Analysis

HeartSciences Inc. (HSCS) EBT Margin (2021 - 2025) Analysis & Trends

HeartSciences (HSCS) has reported EBT Margin for 5 consecutive years, with 97269.0% the latest figure, recorded in Q4 2025.

  • For the quarter ending Q4 2025, EBT Margin changed N/A year-over-year to 97269.0%; the trailing twelve-month figure through Apr 2026 stood at 107010.15% (down 6053758.0% YoY), and the FY2026 full-year result was 212222.92%, down 870513.0% from the prior year.
  • EBT Margin advanced to 97269.0% in Q4 2025 per HSCS's latest filing, from 108305.63% in the prior quarter.
  • Across five years, EBT Margin topped out at 10048.78% in Q3 2021 and bottomed at 108305.63% in Q3 2025.
  • Historically, EBT Margin has averaged 53270.32% across 5 years, with a median of 48741.44% in 2022.
  • The sharpest annual moves came in 2022 and 2024: EBT Margin slumped 3912947 bps in 2022, then soared 5764355 bps in 2024.
  • Over 5 years, EBT Margin stood at 10048.78% in 2021, then tumbled by 389 bps to 49178.25% in 2022, then gained by 9 bps to 44830.28% in 2023, then jumped by 75 bps to 11182.5% in 2024, then plunged by 770 bps to 97269.0% in 2025.
  • According to Business Quant data, EBT Margin over the past three periods registered 97269.0%, 108305.63%, and 48304.62% for Q4 2025, Q3 2025, and Q2 2025 respectively.
Peer Set

Peer Comparison

Historic Data

Historic Data

Download Data
DateValue
Oct 31, 2025 -97,269.00%
Jul 31, 2025 -108,305.63%
Apr 30, 2025 -48,304.62%
Jan 31, 2024 -11,182.50%
Oct 31, 2023 -44,830.28%
Jan 31, 2023 -68,826.05%
Jul 31, 2022 -49,178.25%
Apr 30, 2022 -49,526.22%
Jan 31, 2022 -45,231.90%
Jul 31, 2021 -10,048.78%